WF
YTEN

WealthTrust Fairport’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

WealthTrust Fairport’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3
Closed -$3K – 480
2018
Q4 		$3K Hold
3
– – ﹤0.01% 378
2018
Q3 		$5K Hold
3
– – ﹤0.01% 443
2018
Q2 		$5K Buy
+3
New +$4.76K ﹤0.01% 431

Other funds holding YTEN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HDIM
Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

WealthTrust Fairport's YTEN Position: Q1 2019 in Review

WealthTrust Fairport sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q1 2019, closing a stake of 3 shares — an estimated $3K sold.

WealthTrust Fairport first reported a position in YTEN in Q2 2018 and held it in 3 quarters. The position peaked at $5K in Q3 2018. 10 funds tracked by Wall St. Rank hold YTEN as of Q1 2019.

  • WealthTrust Fairport reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • WealthTrust Fairport sold 3 Yield10 Bioscience, Inc. Common Stock shares in Q1 2019, an estimated $3K.
  • WealthTrust Fairport first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2018 and held it in 3 quarters.
  • WealthTrust Fairport's Yield10 Bioscience, Inc. Common Stock position peaked at $5K in Q3 2018.
  • 10 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q1 2019.

Based on WealthTrust Fairport's 13F filing for Q1 2019, filed 15 May 2019.